| Literature DB >> 26658680 |
Wen-Yu Lu1,2, Jyun-Yu Chen3, Chi-Feng Chang3, Wen-Chin Weng2,4, Wang-Tso Lee2,4,5, Jiann-Shing Shieh3,6.
Abstract
OBJECTIVE: Increasing animal studies supported the harmful effects of prolonged or frequent neonatal seizures in developing brain, including increased risk of later epilepsy. Various nonlinear analytic measures had been applied to investigate the change of brain complexity with age. This study focuses on clarifying the relationship between later epilepsy and the changes of electroencephalogram (EEG) complexity in neonatal seizures.Entities:
Mesh:
Year: 2015 PMID: 26658680 PMCID: PMC4676749 DOI: 10.1371/journal.pone.0144732
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Demographic data.
| Control (Group 1) (n = 9) | Neonatal seizures but no epilepsy (Group 2) (n = 9) | Neonatal seizures with later epilepsy (Group 3) (n = 14) | |
|---|---|---|---|
|
| |||
| F | 3(33) | 2(22) | 11(79) |
| M | 6(67) | 7(78) | 3(21) |
|
| 37.92±1.81 | 38.62±1.44 | 38.50±1.53 |
|
| - | 6 | 4.5 |
|
| |||
| No | 9(100) | 2(22) | 2(14) |
| Perinatal hypoxemia or asphyxia | - | 2(22) | 2(14) |
| Intracranial hemorrhage | - | - | 1(7) |
| Central nervous system infection | - | 1(11) | 1(7) |
| Congenital diaphragmatic hernia | - | 1(11) | 1(7) |
| Congenital heart diseases | - | - | 2(14) |
| Suspected pachygyria | - | - | 1(7) |
| Chromosomal anomaly | - | 1(11) | 4(29) |
| Sepsis | - | 1(11) | - |
| Neonatal jaundice | - | 1(11) | - |
|
| |||
| Motor automatism | - | 4(44.4) | 3(21.4) |
| Tonic | - | - | 1(7.14) |
| Clonic | - | 2(22.2) | 2(14.3) |
| Myoclonic | - | - | 1(7.14) |
| Tonic + Clonic | - | 1(11.1) | 2(14.3) |
| Motor automatism + Clonic | - | 1(11.1) | 3(21.4) |
| Motor automatism + Tonic | - | 1(11.1) | 1(7.14) |
| Tonic + Clonic + Motor automatism | - | - | 1(7.14) |
|
| 40.78±2.38 | 41.78±3.09 | 42.31±2.49 |
|
| |||
| Negative | 9(100) | 3(33) | 2(14) |
| Focal discharges | - | 5(56) | 6(43) |
| Multifocal discharges | - | - | 6(43) |
| Cerebral dysfunction | - | 1(11) | - |
|
| - | 3(33) | 11(79) |
|
| 1(11) | 1/7(14) | 9/11(82) |
SD: standard deviation
*P<0.05 when compared with Group 1 or Group 2.
Summary of antiepileptic drugs used in group 2 and group 3.
| Neonatal seizures but no epilepsy (Group 2) (n = 9) | Neonatal seizures with later epilepsy (Group 3) (n = 14) | |
|---|---|---|
|
| ||
|
| 2 | 0 |
|
| ||
| Lorazepam | 1 | 0 |
| Phenobarbital | 6 | 7 |
| Levetiracetam | 0 | 1 |
|
| ||
| Phenobarbital + Levetiracetam | 0 | 1 |
| Phenobarbital + Vit. B6 | 0 | 2 |
|
| ||
| Phenobarbital + Phenytoin + Topamax | 0 | 1 |
|
| ||
| Lorazepam + Phenobarbital + Phenytoin + Dormicum + Depakine | 0 | 1 |
|
| ||
| Phenobarbital + Vit. B6 + Phenytoin + Topamax + Trileptal + Depakine | 0 | 1 |
Fig 1Demonstrated channels showing the changes of multiscale entropy and complexity index (CI) in three groups calculated from conventional EEG in sleep state (A).
The CI was lower in Group 3 compared with Group 1 or Group 2 (B-F). However, there was no difference in Group 1 and Group 2. Group 1(Control): those without neonatal seizures; Group 2: those with neonatal seizures but no later epilepsy; and Group 3: those with neonatal seizures and later epilepsy.
Summary of complexity index (CI).
| Control | With neonatal seizure but | With neonatal seizure and | |
|---|---|---|---|
| (Group 1) | no epilepsy (Group 2) | later epilepsy (Group 3) | |
|
| 20.3±5.38 | 19.47±5.23 | 16.37±7.90 |
|
| 22.28±5.51 | 20.15±6.55 | 15.28±6.54 |
|
| 19.82±4.01 | 19.75±7.23 | 16.92±7.11 |
|
| 18.60±5.17 | 17.21±5.55 | 15.27±7.36 |
|
| 20.96±5.49 | 19.64±6.64 | 16.02±7.20 |
|
| 21.17±5.74 | 20.17±6.45 | 15.55±6.71 |
|
| 20.96±4.52 | 19.52±7.19 | 17.02±6.61 |
|
| 19.14±4.36 | 18.31±5.85 | 15.54±6.51 |
|
| 17.94±6.25 | 17.37±5.98 | 15.82±7.64 |
|
| 19.41±6.03 | 17.47±6.13 | 16.19±7.67 |
|
| 20.24±4.80 | 18.47±6.70 | 16.26±6.91 |
|
| 18.87±4.97 | 16.71±5.25 | 15.69±8.27 |
|
| 19.41±5.59 | 18.35±8.35 | 16.09±7.71 |
|
| 16.18±5.70 | 19.93±8.25 | 17.67±6.74 |
|
| 22.03±5.51 | 18.80±7.07 | 16.83±6.77 |
|
| 22.20±4.57 | 20.35±7.06 | 15.33±6.94 |
|
| 18.53±5.39 | 17.54±6.78 | 14.96±6.73 |
|
| 20.61±6.34 | 16.97±7.30 | 15.34±7.36 |
|
| 19.49±7.27 | 18.78±7.29 | 16.59±7.08 |
*P<0.05 when compared with Group 1;
** P = 0.053
a Q value = 0.038 when compared with Group 1.
b Q value = 0.059 when compared with Group 1.
c P = 0.060 when compared with Group 2.